Alector (ALEC) Research & Development (2018 - 2026)
Alector (ALEC) reported Research & Development of $17.9 million for Q1 2026, down 46.92% year-over-year from $33.6 million in Q1 2025, and down 44.99% quarter-over-quarter from $32.5 million in Q4 2025.
Alector (ALEC) Research & Development (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Research & Development data on file, last reported at $17.9 million in Q1 2026.
- Research & Development for Q1 2026 came in at $17.9 million, down 46.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $107.3 million (down 38.49% YoY), and the FY2025 annual result was $123.1 million, down 33.81% from the prior year.
- Research & Development fell to $17.9 million in Q1 2026 per ALEC's latest filing, from $32.5 million in the prior quarter.
- Over five years, Research & Development peaked at $54.5 million in Q2 2022 and troughed at $17.9 million in Q1 2026.
- A 5-year average of $42.9 million and a median of $46.3 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2026: Research & Development increased 15.98% in 2022, then tumbled 46.92% in 2026.
- A 5-year view of Research & Development shows it stood at $54.5 million in 2022, then declined by 12.42% to $47.7 million in 2023, then decreased by 2.64% to $46.5 million in 2024, then slumped by 30.13% to $32.5 million in 2025, then tumbled by 44.99% to $17.9 million in 2026.
- Business Quant data shows ALEC's Research & Development at $17.9 million in Q1 2026, $32.5 million in Q4 2025, and $29.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 17.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.86 Mn |
| Dec 31, 2025 | 32.46 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 27.61 Mn |
| Mar 31, 2025 | 33.64 Mn |
| Dec 31, 2024 | 46.46 Mn |
| Sep 30, 2024 | 48.00 Mn |
| Jun 30, 2024 | 46.31 Mn |
| Mar 31, 2024 | 45.17 Mn |
| Dec 31, 2023 | 47.72 Mn |
| Sep 30, 2023 | 46.33 Mn |
| Jun 30, 2023 | 46.18 Mn |
| Mar 31, 2023 | 51.89 Mn |
| Dec 31, 2022 | 54.49 Mn |
| Sep 30, 2022 | 48.35 Mn |
| Jun 30, 2022 | 54.53 Mn |
| Mar 31, 2022 | 53.04 Mn |
| Dec 31, 2021 | 52.79 Mn |
| Sep 30, 2021 | 43.07 Mn |
| Jun 30, 2021 | 47.82 Mn |